Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Agilent Technologies (NY:A)

114.05 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Agilent Technologies

< Previous 1 2 3 4 5 6 7 8 9 Next >
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
From Agilent Technologies Inc.
Via Business Wire
CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
From Agilent Technologies Inc.
Via Business Wire
Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski
From Agilent Technologies Inc.
Via Business Wire
YLCHAT Triumphs on Nasdaq: A Digital Revolution in Financial Integration
Via GlobePRwire
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications
From Agilent Technologies Inc.
Via Business Wire
Agilent to Participate in TD Cowen Health Care Conference
From Agilent Technologies Inc.
Via Business Wire
Agilent Reports First-Quarter Fiscal Year 2025 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Cash Dividend of 24.8 Cents per Share
From Agilent Technologies Inc.
Via Business Wire
Agilent to Announce First-Quarter Fiscal Year 2025 Financial Results on Feb. 26
From Agilent Technologies Inc.
Via Business Wire
Agilent Automated Workflows at SLAS2025: Connecting with Confidence
From Agilent Technologies Inc.
Via Business Wire
Agilent Presents Solutions Innovation Research Awards to Aarhus University, University of Graz, and Imperial College London Scientists
From Agilent Technologies Inc.
Via Business Wire
Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification
From Agilent Technologies Inc.
Via Business Wire
Agilent Reports Fourth-Quarter Fiscal Year 2024 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces New Organizational Structure to Support its Market-Focused Strategy
From Agilent Technologies Inc.
Via Business Wire
Agilent Increases Cash Dividend to 24.8 Cents per Share
From Agilent Technologies Inc.
Via Business Wire
Agilent 2024 Early Career Professor Award Presented to Adeyemi Adeleye
From Agilent Technologies Inc.
Via Business Wire
Agilent Ranks No. 11 on Fortune’s List of Best Workplaces in the World
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research
From Agilent Technologies Inc.
Via Business Wire
Agilent Presents Solutions Innovation Research Awards to Institut National de la Recherche Scientifique and University of Southern California Scientists
From Agilent Technologies Inc.
Via Business Wire
Agilent Revolutionizes HPLC with the Launch of the Agilent Infinity III LC Series
From Agilent Technologies Inc.
Via Business Wire
Agilent to Announce Fourth-Quarter Fiscal Year 2024 Financial Results on Nov. 25
From Agilent Technologies Inc.
Via Business Wire
Agilent to Host Analyst and Investor Day on Dec. 17, 2024
From Agilent Technologies Inc.
Via Business Wire
Agilent Completes Acquisition of BIOVECTRA
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Cash Dividend of 23.6 Cents per Share
From Agilent Technologies Inc.
Via Business Wire
Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine
From Agilent Technologies Inc.
Via Business Wire
Agilent Technologies Thrives From the Forever Chemicals Crackdown
Agilent Technologies Inc. (NYSE: A) is a diversified global leader in the life sciences, diagnostics and applied chemical markets. 
Via MarketBeat
Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance
From Agilent Technologies Inc.
Via Business Wire
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy
From Agilent Technologies Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.